Millennium and BZL Biologics agree to develop antibodies against prostate cancer.(Brief Article): An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on April 1, 2001. The length of the article is 1182 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Millennium and BZL Biologics agree to develop antibodies against prostate cancer.(Brief Article)
Publication:BIOTECH Patent News (Newsletter)
Date: April 1, 2001
Publisher: Biotech Patent News
Volume: 15 Issue: 4 Page: NA

Article Type: Brief Article

Distributed by Thomson Gale